IRVINE, Calif., Aug. 20, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (NYSE American: MRIC) announces that its ClearPoint Neuro Navigation System has recently completed its 3,000th neurosurgical procedure.

“This milestone is a testament to the value surgeons are placing on precision guided therapy, especially in neurosurgery where the stakes are the highest,” commented Joe Burnett, President and CEO of MRI Interventions. “Although the timing is coincidental, we were thrilled to share this success with the team at the University of California, San Francisco, who have partnered with us for the last decade in refining our platform and ensuring the voice of not only the doctor, but also that of the patient, is included in every improvement. It is also important to note that not only did UCSF perform the 3,000th case using ClearPoint, they also performed the 3,001st case that same day. UCSF is among the now ten centers scheduling two cases per day utilizing the same MRI scanner, which has been a strategic push for us in the past year.”


About MRI Interventions, Inc.
MRI Interventions is a leading platform company for MRI-guided neurosurgery procedures, including deep-brain stimulation, ablation, aspiration, biopsy, and gene therapy delivery. The ClearPoint Neuro Navigation System is FDA cleared and CE marked, and is installed in more than 55 surgical centers in the U.S. To date, more than 3,000 procedures have been performed leveraging the sub-millimetric accuracy of the ClearPoint platform.

Operating Room Homepage